首页> 美国卫生研究院文献>Frontiers in Neurology >The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands
【2h】

The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands

机译:姑息治疗在慢性进行性神经疾病中的作用-荷兰神经科医生的一项调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Chronic progressive neurological diseases like high grade glioma (HGG), Parkinson's disease (PD), and multiple sclerosis (MS) are incurable, and associated with increasing disability including cognitive impairment, and reduced life expectancy. Patients with these diseases have complex care needs. Therefore, timely advance care planning (ACP) is required. Our aim was to investigate timing and content of discussions on treatment restrictions, i.e., to initiate, withhold, or withdraw treatment in patients with HGG, PD, and MS, from the neurologists' perspective.>Methods: We performed a national online survey amongst consultants in neurology and residents in The Netherlands. The questionnaire focused on their daily practice concerning timing and content of discussions on treatment restrictions with patients suffering from HGG, PD or MS. We also inquired about education and training in discussing these issues.>Results: A total of 125 respondents [89 neurologists (71%), 62% male, with a median age of 44 years, and 36 residents (29%), 31% male with a median age of 29 years] responded. Initial discussions on treatment restrictions were said to take place during the first year after diagnosis in 28% of patients with HGG, and commonly no earlier than in the terminal phase in patients with PD and MS. In all conditions, significant cognitive decline was the most important trigger to advance discussions, followed by physical decline, and initiation of the terminal phase. Most discussed issues included ventilation, resuscitation, and admission to the intensive care unit. More than half of the consultants in neurology and residents felt that they needed (more) education and training in having discussions on treatment restrictions.>Conclusion: In patients with HGG discussions on treatment restrictions are initiated earlier than in patients with PD or MS. However, in all three diseases these discussions usually take place when significant physical and cognitive decline has become apparent and commonly mark the initiation of end-of-life care. More than half of the responding consultants in neurology and residents feel the need for improvement of their skills in performing these discussions.
机译:>背景:不能治愈慢性进行性神经系统疾病,例如高级神经胶质瘤(HGG),帕金森氏病(PD)和多发性硬化症(MS),并与残疾增加有关,包括认知障碍和预期寿命缩短。这些疾病的患者有复杂的护理需求。因此,需要及时的预先护理计划(ACP)。我们的目的是从神经科医生的角度研究有关治疗限制的讨论的时机和内容,即开始,停止或退出HGG,PD和MS患者的治疗。>方法:在神经病学顾问和荷兰居民中进行了一项全国性在线调查。该调查表侧重于他们的日常实践,涉及对患有HGG,PD或MS的患者进行治疗限制的时机和讨论内容。我们还询问了有关讨论这些问题的教育和培训。>结果::共有125位受访者[89位神经科医生(71%),62%男性,中位年龄44岁,36位居民( 29%),31%的男性(平均年龄为29岁)做出了回应。据称,关于治疗限制的初步讨论发生在诊断后的第一年中,有28%的HGG患者,通常不早于PD和MS患者的末期。在所有情况下,明显的认知能力下降是进行讨论的最重要诱因,其次是身体下降和末期阶段的开始。讨论最多的问题包括通风,复苏和重症监护病房的入院。半数以上的神经病学和住院顾问认为,他们需要(更多)教育和培训来就治疗限制进行讨论。>结论:在HGG患者中,关于治疗限制的讨论要比在患者中提早进行与PD或MS。但是,在所有这三种疾病中,通常会在明显的身体和认知能力下降变得明显并通常标志着临终护理开始时进行这些讨论。神经科和住院医师中超过一半的回应顾问认为有必要提高他们进行这些讨论的技巧。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号